The Melanoma Skin Cancer Section in Diagnosis and Treatment by Cancer Type Has Been Updated

Melanoma is a type of skin cancer. Skin cancers are divided into melanomas and nonmelanoma skin cancers. Although melanoma accounts for approximately %5 of skin cancers, it is the skin cancer that causes the most deaths. It is also one of the cancers with the fastest-growing incidence: a study conducted in England found that, compared with 50 years ago, melanoma incidence had increased 5-fold. The main reason is increased time spent in the sun, particularly during holidays. Physicians' improved recognition and monitoring of melanoma findings can also be considered an important factor. Recent studies have also shown that obesity increases melanoma risk.
The skin is the largest organ in the body and has many different functions. Covering the internal organs, it protects the body against potential injuries, prevents excessive water and fluid loss, and helps the body obtain vitamin D. It also protects against microbes such as bacteria and harmful ultraviolet (UV) rays and helps regulate body temperature. Melanoma can develop from moles.
Melanoma is a skin cancer that begins in cells called melanocytes, which give skin its color, and is called malignant melanoma or cutaneous melanoma. Because most melanoma cells continue to produce melanin, the tumor is usually brown or black. However, some melanomas do not produce melanin. In these cases, the cancer may appear pink, tan, or even white. Melanoma can develop on moles present from birth or appearing later and can occur anywhere on the skin covering the body, including the scalp and soles of the feet.
This cancer is common on the neck and back in men and on the legs, neck, and face in women. However, it can also develop on the palms, soles, and within the nails. It can also occur, though rarely, in the eyes, mouth, genital region, or anal region. Melanoma, a treatable cancer when diagnosed early, can become a cancer with reduced chances of treatment when it spreads rapidly.
Multidisciplinary teamwork is very important in melanoma. The general surgeon, radiation oncologist, medical oncologist, nuclear medicine specialist, radiologist, interventional radiologist, pathologist, and molecular pathology team should all work together with a shared perspective. Planning and multidisciplinary evaluation at the beginning of the disease are extremely important for establishing a roadmap for the future.
Melanoma has been the most prominent and extensively studied disease in cancer medicine in recent years. This is because new-generation drugs called immunotherapies were first tested successfully in melanoma. In 2010, ipilimumab (Yervoy), an immunotherapy drug successful in clinical trials, was shown to make a significant contribution to survival in advanced (metastatic) melanoma. Following targeted drugs developed against cancer cells, these studies brought a new revolution and a success story. Two drugs developed after Yervoy's success, nivolumab (Opdivo) and pembrolizumab (Keytruda), were not only proven effective in malignant melanoma but also in another extremely difficult-to-manage cancer, lung cancer.
Now let us examine melanoma skin cancer together..
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.